Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

Chief executive officer Paul Hudson is ratcheting up Sanofi’s drug-development programme to create more medicines like ...

Viking Therapeutics plans to advance its obesity drug VK2735 to Phase III trials by late 2024, following Phase II results ...

GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. The UK ...